This precision approach helps you experience the weight loss benefits of semaglutide while minimizing digestive side effects and enjoying flavorful, satisfying meals aligned with your biology
Focus on sustained vitality rather than dramatic short-term changes
Tirzepatide, marketed under the brand names Mounjaro and Zepbound, is a dual GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide) receptor agonist (substance that binds to a receptor and triggers a response in a cell, causing the cell to become more active) approved by the FDA for the treatment of type 2 diabetes and obesity
Since many people who are candidates for GLP-1s also have risk factors for cardiovascular issues, establishing this baseline is critical
This finding highlights the importance of considering sex differences and hormonal status in preclinical evaluations to enhance clinical translation
In some cases, however, insurance plans may cover the medications with prior authorization from a healthcare provider